Clinical Trial Update: Utilizing Non-Invasive Fibroscan® Technology to Identify Genetic Markers for Fatty Liver Progression

View source ↗

Summary

A completed clinical trial evaluating non-invasive Fibroscan technology to identify genetic markers for progression of Non-alcoholic Fatty Liver Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: UNC Nutrition Research Institute | Conditions: Non-alcoholic Fatty Liver Disease | Status: COMPLETED